ISDS Case Map
medicines
Indian pharmaceutical firms and the network of public health groups have separately urged the government to keep patent-related issues out of the ongoing talks for the proposed India-EU free trade agreement.
It took two years of secret suffering and gut-wrenching diarrhea to make Lumkile Sizila face the fact that he had HIV.
The New Zealand government has dismissed the possibility it would scrap its drug-funding system as part of the price of a free-trade deal with the United States.
The medicines industry says reforms are likely be needed to the way the Government's drug-buying agency Pharmac operates if New Zealand is to reach a free trade deal with the United States.
Fatima Mello of the Brazil Network for the Integration of Peoples worked with other civil society groups across South America in order to bring down the proposed Free Trade Agreement of the Americas. Here she discusses the campaign and lessons learned:
Civil society and public health groups from India, Brazil and several other countries today vehemently objected to the proposed India-European Union Free Trade Agreement (FTA).
In a report submitted to the United Nations Human Rights Council over the weekend, PIJIP joined with HIV treatment advocacy organizations Health Global Access Project (HealthGAP) and the European Community Advisory Board to call for a human rights review of U.S. trade policy on access to medicines.
A new accord designed to bolster political and economic ties between the European Union and Central America could result in greater seizures of medicines whenever pharmaceutical companies allege that their patents have been infringed, public health advocates have warned.
The Delhi Network of Positive People (DNP+) is calling on the EU Trade Commissioner to come clean on the demands and pressures being placed by the European Union on the Government of India to accept TRIPS-plus measures that will have a severe, adverse impact on access to safe, effective and affordable medicines in India and across the developing world.
A group of nine Georgetown Law students have written a report, "Prescription for Failure: Health and Intellectual Property in the Dominican Republic," which finds that U.S. efforts to increase intellectual property protections in the Dominican Republic may lead to sharp increases in the cost of lifesaving drugs and, as a result, the declining health and even deaths of those who may be unable to afford them.
